MARKET

QURE

QURE

Uniqure
NASDAQ
13.00
+3.61
+38.45%
After Hours: 12.95 -0.05 -0.38% 16:49 04/17 EDT
OPEN
13.01
PREV CLOSE
9.39
HIGH
14.16
LOW
12.54
VOLUME
14.43M
TURNOVER
--
52 WEEK HIGH
19.18
52 WEEK LOW
3.730
MARKET CAP
703.00M
P/E (TTM)
-2.6400
1D
5D
1M
3M
1Y
5Y
1D
Why Is Gene Therapy Developer uniQure Stock Trading Higher On Thursday?
Benzinga · 6h ago
uniQure jumps on FDA breakthrough tag for Huntington’s disease drug
Seeking Alpha · 7h ago
Pre-Market Most Active for Apr 17, 2025 : HTZ, TSLL, NVDA, TQQQ, SQQQ, QURE, TSM, HIMS, NVO, UNH, BABA, NIO
NASDAQ · 8h ago
UniQure Gets Breakthrough Therapy Status For AMT-130 To Treat Huntingtons Disease
NASDAQ · 8h ago
uniQure granted Breakthrough Therapy Designation for AMT-130 in Huntington’s
TipRanks · 9h ago
uniQure N.V. Receives FDA Breakthrough Therapy Designation for AMT-130 in Huntington's Disease Treatment
NASDAQ · 9h ago
FDA Grants Breakthrough Therapy Designation To uniQure's AMT-130 For Treatment Of Huntington's Disease
Benzinga · 9h ago
uniQure Amends CEO Employment Agreement
TipRanks · 1d ago
More
About QURE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

Webull offers Uniqure NV stock information, including NASDAQ: QURE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QURE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QURE stock methods without spending real money on the virtual paper trading platform.